Global Information
회사소개 | 문의 | 비교리스트

세계의 비타민 K2 시장 : 예측

Global Vitamin K2 Market Research Report Forecast to 2023

리서치사 Market Research Future
발행일 2019년 04월 상품 코드 851699
페이지 정보 영문 120 Pages
가격
US $ 4,450 ₩ 5,288,000 Unprintable PDF (Single User License)
US $ 6,250 ₩ 7,427,000 Printable PDF (Corporate User License)


세계의 비타민 K2 시장 : 예측 Global Vitamin K2 Market Research Report Forecast to 2023
발행일 : 2019년 04월 페이지 정보 : 영문 120 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 비타민 K2(메타퀴논) 시장을 분석했으며, 제품 개요와 시장의 기본 구조, 주요 시장 성장 촉진요인 및 억제요인, 전체적인 시장 동향 전망(과거 3년간, 향후 6년간), 제품 종류별·원료별·형태별·용도별·지역별 상세 동향, 시장 점유율 구조, 주요 기업 개요·실적·전략 등의 정보를 정리하여 전해드립니다.

제1장 서론

제2장 주요 요약

제3장 시장 개요

제4장 분석 방법

  • 분석 프로세스
  • 1차 조사
  • 2차 조사
  • 시장 규모 추정치
  • 시장 예측 모델
  • 서론
  • 시장 성장 촉진요인
  • 시장 기회

제5장 시장 요인 분석

  • Porter's Five Forces 분석
  • 공급망 분석

제6장 세계의 비타민 K2 시장 : 제품 종류별

  • 서론
  • MK-7(메타퀴논 7)
  • MK-4(메타퀴논 4)

제7장 세계의 비타민 K2 시장 : 원료별

  • 서론
  • 천연
  • 합성

제8장 세계의 비타민 K2 시장 : 형태별

  • 서론
  • 분말
  • 오일

제9장 세계의 비타민 K2 시장 : 용도별

  • 서론
  • 뉴트라슈티컬 및 식품
  • 의약품

제10장 세계의 비타민 K2 시장 : 지역별

  • 서론
  • 아메리카(북미(미국, 캐나다), 라틴아메리카)
  • 유럽(서유럽(영국, 독일, 프랑스, 이탈리아, 스페인 등), 동유럽)
  • 아시아태평양(호주, 일본, 중국, 인도, 한국 등)
  • 중동 및 아프리카

제11장 경쟁 환경

  • 서론
  • 기업별 시장 점유율 분석

제12장 기업 개요

  • Kappa Bioscience
  • NattoPharma
  • Gnosis SpA
  • Viridis BioPharma
  • Seebio Biotech
  • DSM
  • Danisco A/S
  • Geneferm Biotechnology Co. Ltd
  • Frutarom
  • Kyowa Hakko Bio Co. Ltd

제13장 부록

LSH 19.06.10

List of Tables

  • TABLE 1 MARKET SYNOPSIS
  • TABLE 2 LIST OF ASSUMPTIONS
  • TABLE 3 GLOBAL VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 4 GLOBAL VITAMIN K2 MARKET FOR MK-7, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 5 GLOBAL VITAMIN K2 MARKET FOR MK-4, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 6 GLOBAL VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 7 GLOBAL VITAMIN K2 MARKET FOR NATURAL, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 8 GLOBAL VITAMIN K2 MARKET FOR SYNTHETIC, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 9 GLOBAL VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 10 GLOBAL VITAMIN K2 MARKET FOR POWDER, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 11 GLOBAL VITAMIN K2 MARKET FOR OIL, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 12 GLOBAL VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 13 GLOBAL VITAMIN K2 MARKET FOR NUTRACEUTICAL AND FOOD, BY REGION 2015-2023 (USD MILLION)
  • TABLE 14 GLOBAL VITAMIN K2 MARKET FOR PHARMACEUTICAL, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 15 GLOBAL VITAMIN K2 MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 16 AMERICAS: VITAMIN K2 MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 17 AMERICAS: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 18 AMERICAS: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 19 AMERICAS: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 20 AMERICAS: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 21 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 22 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 23 NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 24 NORTH AMERICA: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 25 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 26 US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 27 US: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 28 US: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 29 US: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 30 CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 31 CANADA: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 32 CANADA: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 33 CANADA: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 34 LATIN AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 35 LATIN AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 36 LATIN AMERICA: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 37 LATIN AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 38 EUROPE: VITAMIN K2 MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 39 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 40 EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 41 EUROPE: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 42 EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 43 WESTERN EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 44 WESTERN EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 45 WESTERN EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 46 WESTERN EUROPE: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 47 WESTERN EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 48 UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 49 UK: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 50 UK: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 51 UK: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 52 GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 53 GERMANY: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 54 GERMANY: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 55 GERMANY: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 56 FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 57 FRANCE: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 58 FRANCE: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 59 FRANCE: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 60 ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 61 ITALY: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 62 ITALY: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 63 ITALY: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 64 SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 65 SPAIN: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 66 SPAIN: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 67 SPAIN: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 68 REST OF WESTERN EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 69 REST OF WESTERN EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 70 REST OF WESTERN EUROPE: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 71 REST OF WESTERN EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 72 EASTERN EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 73 EASTERN EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 74 EASTERN EUROPE: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 75 EASTERN EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 76 ASIA-PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2015-2023 (USD MILLION)
  • TABLE 77 ASIA-PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 78 ASIA-PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 79 ASIA-PACIFIC: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 80 ASIA-PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 81 AUSTRALIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 82 AUSTRALIA: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 83 AUSTRALIA: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 84 AUSTRALIA: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 85 JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 86 JAPAN: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 87 JAPAN: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 88 JAPAN: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 89 CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 90 CHINA: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 91 CHINA: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 92 CHINA: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 93 INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 94 INDIA: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 95 INDIA: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 96 INDIA: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 97 SOUTH KOREA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 98 SOUTH KOREA: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 99 SOUTH KOREA: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 100 SOUTH KOREA: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 101 REST OF ASIA-PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 102 REST OF ASIA-PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 103 REST OF ASIA-PACIFIC: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 104 REST OF ASIA-PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 105 MIDDLE EAST & AFRICA: VITAMIN K2 MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 106 MIDDLE EAST & AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 107 MIDDLE EAST & AFRICA: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 108 MIDDLE EAST & AFRICA: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 109 MIDDLE EAST & AFRICA: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 110 MIDDLE EAST: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 111 MIDDLE EAST: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 112 MIDDLE EAST: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 113 MIDDLE EAST: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 114 AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2015-2023 (USD MILLION)
  • TABLE 115 AFRICA: VITAMIN K2 MARKET, BY SOURCE, 2015-2023 (USD MILLION)
  • TABLE 116 AFRICA: VITAMIN K2 MARKET, BY FORM, 2015-2023 (USD MILLION)
  • TABLE 117 AFRICA: VITAMIN K2 MARKET, BY APPLICATION, 2015-2023 (USD MILLION)

List of Figures

  • FIGURE 1 RESEARCH PROCESS OF MRFR
  • FIGURE 2 TOP-DOWN & BOTTOM-UP APPROACHES
  • FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL VITAMIN K2 MARKET
  • FIGURE 4 PORTER'S FIVE FORCES ANALYSIS: GLOBAL VITAMIN K2 MARKET
  • FIGURE 5 SUPPLY CHAIN ANALYSIS: GLOBAL VITAMIN K2 MARKET
  • FIGURE 6 GLOBAL VITAMIN K2 MARKET SHARE, BY TYPE, 2017(%)
  • FIGURE 7 GLOBAL VITAMIN K2 MARKET, BY TYPE, 2017 & 2023 (USD MILLION)
  • FIGURE 8 GLOBAL VITAMIN K2 MARKET SHARE, BY SOURCE, 2017 (%)
  • FIGURE 9 GLOBAL VITAMIN K2 MARKET, BY SOURCE, 2017 & 2023 (USD MILLION)
  • FIGURE 10 GLOBAL VITAMIN K2 MARKET SHARE, BY FORM, 2017(%)
  • FIGURE 11 GLOBAL VITAMIN K2 MARKET, BY FORM, 2017 & 2023 (USD MILLION)
  • FIGURE 12 GLOBAL VITAMIN K2 MARKET SHARE, BY APPLICATION, 2017(%)
  • FIGURE 13 GLOBAL VITAMIN K2 MARKET, BY APPLICATION, 2017 & 2023 (USD MILLION)
  • FIGURE 14 GLOBAL VITAMIN K2 MARKET SHARE, BY REGION, 2017(%)
  • FIGURE 15 GLOBAL VITAMIN K2 MARKET, BY REGION, 2017 & 2023 (USD MILLION)
  • FIGURE 16 AMERICAS: VITAMIN K2 MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 17 EUROPE: VITAMIN K2 MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 18 ASIA-PACIFIC: VITAMIN K2 MARKET SHARE, BY COUNTRY, 2017 (%)
  • FIGURE 19 MIDDLE EAST & AFRICA: VITAMIN K2 MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 20 GLOBAL VITAMIN K2 MARKET, COMPANY MARKET SHARE ANALYSIS, 2017 (%)

Vitamin K2 Market Research Report: by Product Type (MK-7, MK-4, Others), by Source (Natural, Synthetic), by Form (Oil, Powder, Others), by Application (Nutraceutical & Food, Pharmaceutical), and Region - Global Forecast till 2023

Market analysis

Vitamin K2, otherwise called menaquinones, are a compound group known for averting cardiovascular maladies and bone illnesses. The nutrient is in charge of guaranteeing calcium consumed by the bone network and avert its disposition in the arteries. The global vitamin K2 market is assessed to contact a valuation of USD 228.27 million by 2023, according to the most recent discoveries of Market Research Future (MRFR). It is anticipated to enlist 5.80% CAGR over the gauge time frame (2018-2025). It was recently esteemed at USD 45 million of every 2017. It is principally determined by the ascent in nutrient inadequacy cases. Increment in wellbeing awareness combined with the tendency of customers towards dietary enhancements can drive the global vitamin K2 market development. Rising instances of osteoporosis which can quicken maturing of tissues is another factor which can decidedly affect the market. However, exacting guidelines by government bureaucratic organizations for endorsement of supplements can go about as a development obstacle.

Market segmentation

The global vitamin K2 market is bifurcated on the basis of source, product type, form, application and regional demand. On the basis of its product type, the market is divided into MK-4, MK-7, and others. Based on its sources, the market is segmented into synthetic and nautral. On the basis of its form, the market is bifurcated into powder and oil. Based on its applications, the market include pharmaceutical and nutraceutical & food.

Regional analysis

Geographically, the global vitamin K2 market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

DSM (The Netherlands), Danisco A/S (U.S.), Geneferm Biotechnology Co. Ltd. (Taiwan), Frutarom (Israel), and Kyowa Hakko Bio Co. Ltd. (Japan), Kappa Bioscience (Norway), NattoPharma (Norway), Gnosis SpA (Italy), Viridis BioPharma (India), Seebio Biotech (China), among others are some of the key players in the global vitamin K2 market.

Table of Contents

1 Report Prologue

2 Executive Summary

3 Market Introduction

  • 3.1 Definition
  • 3.2 Scope of the Study
  • 3.3 List of Assumptions
  • 3.4 Market Structure

4 Research Methodology

  • 4.1 Research Process
  • 4.2 Primary Research
  • 4.3 Secondary Research
  • 4.4 Market Size Estimation
  • 4.5 Forecast Model
  • 4.6 Introduction
  • 4.7 Drivers
    • 4.7.1 Increasing patient pool suffering from vitamin deficiency
    • 4.7.2 Increasing demand for nutraceutical products containing vitamin K2
    • 4.7.3 Increasing cases of osteoporosis
  • 4.8 Restraints
    • 4.8.1 Stringent regulations for nutraceuticals adversely affect the market
  • 4.9 Opportunity
    • 4.9.1 Multifunctional ingredients

5 Market Factor Analysis

  • 5.1 Porter's Five Forces Model
    • 5.1.1 Bargaining Power of Suppliers
    • 5.1.2 Bargaining Power of Buyers
    • 5.1.3 Threat of New Entrants
    • 5.1.4 Threat of Substitutes
    • 5.1.5 Rivalry
  • 5.2 Supply Chain Analysis
    • 5.2.1 Raw Material Planning & Procurement
      • 5.2.1.1 Fermentation
      • 5.2.1.2 Filtration
      • 5.2.1.3 Extraction
      • 5.2.1.4 Filtration Purification
    • 5.2.2 Packaging
    • 5.2.3 Transportation
    • 5.2.4 Distribution Marketing & Sales
    • 5.2.5 Post-sales Services

6 Global Vitamin K2 Market, by Product Type

  • 6.1 Introduction
  • 6.2 MK-7
  • 6.3 MK-4

7 Global Vitamin K2 Market, by Source

  • 7.1 Introduction
  • 7.2 Natural
  • 7.3 Synthetic

8 Global Vitamin K2 Market, by Form

  • 8.1 Introduction
  • 8.2 Powder
  • 8.3 Oil

9 Global Vitamin K2 Market, by Application

  • 9.1 Introduction
  • 9.2 Nutraceutical and Food
  • 9.3 Pharmaceutical

10 Global Vitamin K2 Market, by Region

  • 10.1 Introduction
  • 10.2 Americas
    • 10.2.1 North America
      • 10.2.1.1 US
      • 10.2.1.2 Canada
    • 10.2.2 Latin America
  • 10.3 Europe
    • 10.3.1 Western Europe
      • 10.3.1.1 UK
      • 10.3.1.2 Germany
      • 10.3.1.3 France
      • 10.3.1.4 Italy
      • 10.3.1.5 Spain
      • 10.3.1.6 Rest of Western Europe
    • 10.3.2 Eastern Europe
  • 10.4 Asia-Pacific
    • 10.4.1 Australia
    • 10.4.2 Japan
    • 10.4.3 China
    • 10.4.4 India
    • 10.4.5 South Korea
    • 10.4.6 Rest of Asia-Pacific
  • 10.5 Middle East & Africa
    • 10.5.1 Middle East
    • 10.5.2 Africa

11 Competitive Landscape

  • 11.1 Introduction
  • 11.2 Company Market Share Analysis

12 Company Profiles

  • 12.1 Kappa Bioscience
    • 12.1.1 Company Overview
    • 12.1.2 Financial Overview
    • 12.1.3 Products/Services Offered
    • 12.1.4 Key Developments
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Strategies
  • 12.2 NattoPharma
    • 12.2.1 Company Overview
    • 12.2.2 Financial Overview
    • 12.2.3 Products/Services Offered
    • 12.2.4 Key Developments
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Strategies
  • 12.3 Gnosis SpA
    • 12.3.1 Company Overview
    • 12.3.2 Financial Overview
    • 12.3.3 Products/Services Offered
    • 12.3.4 Key Developments
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Strategies
  • 12.4 Viridis BioPharma
    • 12.4.1 Company Overview
    • 12.4.2 Financial Overview
    • 12.4.3 Products/Services Offered
    • 12.4.4 Key Developments
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Strategies
  • 12.5 Seebio Biotech
    • 12.5.1 Company Overview
    • 12.5.2 Financial Overview
    • 12.5.3 Products/Services Offered
    • 12.5.4 Key Developments
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Strategies
  • 12.6 DSM
    • 12.6.1 Company Overview
    • 12.6.2 Financial Overview
    • 12.6.3 Products/Services Offered
    • 12.6.4 Key Developments
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Strategies
  • 12.7 Danisco A/S
    • 12.7.1 Company Overview
    • 12.7.2 Financial Overview
    • 12.7.3 Products/Services Offered
    • 12.7.4 Key Developments
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Strategies
  • 12.8 Geneferm Biotechnology Co. Ltd
    • 12.8.1 Company Overview
    • 12.8.2 Financial Overview
    • 12.8.3 Products/Services Offered
    • 12.8.4 Key Developments
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Strategies
  • 12.9 Frutarom
    • 12.9.1 Company Overview
    • 12.9.2 Financial Overview
    • 12.9.3 Products/Services Offered
    • 12.9.4 Key Developments
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Strategies
  • 12.1 Kyowa Hakko Bio Co. Ltd
    • 12.10.1 Company Overview
    • 12.10.2 Financial Overview
    • 12.10.3 Products/Services Offered
    • 12.10.4 Key Developments
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Strategies

13 Appendix

  • 13.1 Discussion Blueprint
Back to Top
전화 문의
F A Q